FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

9 letters match. Newest first.

  1. Ketacyn Pharmaceuticals / www.ketacynpharma.com

    FDA told Ketacyn Pharmaceuticals to stop selling unapproved ketamine injection and ketamine gummies to U.S. consumers online.

    High risk
  2. www.usmedschoice.com

    FDA warned www.usmedschoice.com for selling unapproved and misbranded opioids, benzodiazepines, and stimulants online without prescriptions.

    High risk
  3. www.mysteroidsmarket.com

    FDA warns Israel-based website mysteroidsmarket.com for selling unapproved and misbranded stimulants and benzodiazepines to U.S. consumers.

    High risk
  4. www.weightcrunchshop.com

    FDA warned www.weightcrunchshop.com about selling unapproved and misbranded semaglutide and oxycodone drugs to U.S. consumers online.

    High risk
  5. www.directpharmashop.net

    FDA warned DirectPharmaShop.net over selling unapproved, misbranded antipsychotics to U.S. consumers online.

    High risk
  6. www.semaspace.com

    FDA warned semaspace.com for selling unapproved, misbranded injectable semaglutide drugs online without prescriptions.

    High risk
  7. www.alphamedstore.com

    FDA warned www.alphamedstore.com that it sells unapproved, illegally labeled opioid drugs, including Zomorph morphine capsules, to U.S. consumers.

    High risk
  8. kubapharm.com

    FDA and DEA warned kubapharm.com it unlawfully sells high-abuse-risk stimulants, including Adderall, online without required registrations or prescriptions.

    High risk
  9. Dream Pharmacy 24/7 Enterprises Limited 2018

    FDA warned Dream Pharmacy 24/7 for selling unapproved, misbranded opioids, benzodiazepines, and hydroxychloroquine online without prescriptions.

    High risk